Obesity Medicine Course, Parts 1 and 2: Obesity and the Liver—From Metabolic Dysfunction–Associated Steatotic Liver Disease to Cardiovascular-Kidney-Liver-Metabolic Diseases (Ticketed)

Nov 05 2026
Convention Center: Bluebird Ballroom 2ABC
1:00 PM - 4:30 PM
Ticketed event Ticketed Event
Captured/recorded session Recorded
CE Credits CE Credits

World Class Speakers

Arun Sanyal

Presenter
Arun Sanyal, MD, FAASLD

Fernando Bril

Presenter
Fernando Bril, MD

Cynthia A Moylan

Presenter
Cynthia A Moylan, MD, MHS, FAASLD

Jaime Chu

Presenter
Jaime Chu, MD, FAASLD

Anna Mae E Diehl

Presenter
Anna Mae E Diehl, MD, FAASLD

Alina M. Allen

Presenter
Alina M. Allen, MD

Wajahat Z Mehal

Presenter
Wajahat Z Mehal, MD, FAASLD

Zobair M Younossi

Presenter
Zobair M Younossi, MD, MPH, FAASLD

Amreen Dinani

Moderator
Amreen Dinani, MD FRCPC

Silvia Vilarinho

Moderator
Silvia Vilarinho, MD, PhD

Mitchell A Mah'moud

Moderator
Mitchell A Mah'moud, MD, FACG, AGAF, FAASLD

Alina M. Allen

Moderator
Alina M. Allen, MD

Description

This timely course provides a comprehensive overview of obesity as a multisystem disease with major implications for liver health. Using the frameworks of metabolic dysfunction–associated steatotic liver disease (MASLD) and cardiometabolic-kidney-liver-metabolic disease (CKLM), the course integrates pathophysiology, noninvasive risk stratification, and therapeutic approaches across lifestyle, pharmacologic, and procedural interventions. Panelists emphasize clinically relevant concepts for hepatologists navigating the rapidly evolving obesity and metabolic disease landscape.

Presentations

1:40 PM - 2:00 PM
Convention Center - Bluebird Ballroom 2ABC
Recorded session Ticketed event

Metabolic Dysfunction–Associated Steatotic Liver Disease in the Context of Cardiovascular-Kidney-Liver-Metabolic Disease

Arun Sanyal, MD, FAASLD | Presenter
3:20 PM - 3:40 PM
Convention Center - Bluebird Ballroom 2ABC
Recorded session Ticketed event

Pharmacologic Management of Obesity and Metabolic Dysfunction–Associated Steatotic Liver Disease

Fernando Bril, MD | Presenter
3:40 PM - 4:00 PM
Convention Center - Bluebird Ballroom 2ABC
Recorded session Ticketed event

Alcohol and Other Disease Modifiers in Special Populations

Cynthia A Moylan, MD, MHS, FAASLD | Presenter
4:00 PM - 4:20 PM
Convention Center - Bluebird Ballroom 2ABC
Recorded session Ticketed event

Management of Obesity and Cardiovascular-Kidney-Liver-Metabolic Disease in Children

Jaime Chu, MD, FAASLD | Presenter
1:20 PM - 1:40 PM
Convention Center - Bluebird Ballroom 2ABC
Recorded session Ticketed event

Pathophysiology of Metabolic Dysfunction–Associated Steatotic Liver Disease in Obesity

Anna Mae E Diehl, MD, FAASLD | Presenter
2:00 PM - 2:20 PM
Convention Center - Bluebird Ballroom 2ABC
Recorded session Ticketed event

Noninvasive Assessment of Liver Disease in Obesity

Alina M. Allen, MD | Presenter
3:00 PM - 3:20 PM
Convention Center - Bluebird Ballroom 2ABC
Recorded session Ticketed event

Metabolic and Weight Loss Interventions

Wajahat Z Mehal, MD, FAASLD | Presenter
1:00 PM - 1:20 PM
Convention Center - Bluebird Ballroom 2ABC
Recorded session Ticketed event

Obesity as a Multisystem Liver Disease

Zobair M Younossi, MD, MPH, FAASLD | Presenter

Objectives

  • Describe the mechanisms by which obesity drives liver injury and fibrosis within the metabolic dysfunctionassociated steatotic liver disease (MASLD) and cardiovascular-kidney-liver-metabolic disease (CKLM) frameworks.
  • Apply noninvasive tools to risk stratify liver disease in patients with obesity, recognizing their limitations.
  • Evaluate the impact of lifestyle, surgical, and pharmacologic obesity treatments on liver, cardiovascular, and kidney outcomes.
  • Outline a multisystem approach to the management of obesity-related liver disease in clinical practice.

Copyright © 2026 American Association for the Study of Liver Diseases

AASLD 2026